These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 9512108)
21. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Lin AT; Clements PJ; Furst DE Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302 [TBL] [Abstract][Full Text] [Related]
22. Interstitial lung disease in systemic sclerosis: current and future treatment. Giacomelli R; Liakouli V; Berardicurti O; Ruscitti P; Di Benedetto P; Carubbi F; Guggino G; Di Bartolomeo S; Ciccia F; Triolo G; Cipriani P Rheumatol Int; 2017 Jun; 37(6):853-863. PubMed ID: 28063071 [TBL] [Abstract][Full Text] [Related]
29. Development of agents for the treatment of systemic sclerosis. Herrick AL Expert Opin Investig Drugs; 2001 Jul; 10(7):1255-64. PubMed ID: 11772249 [TBL] [Abstract][Full Text] [Related]
30. Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group. Airò P; Rossi M; Scarsi M; Danieli E; Grottolo A; Zambruni A Clin Exp Rheumatol; 2007; 25(5):722-7. PubMed ID: 18078620 [TBL] [Abstract][Full Text] [Related]
31. Old medications and new targeted therapies in systemic sclerosis. Nagaraja V; Denton CP; Khanna D Rheumatology (Oxford); 2015 Nov; 54(11):1944-53. PubMed ID: 25065013 [TBL] [Abstract][Full Text] [Related]
35. Prospects for improving outcomes in systemic sclerosis-related pulmonary hypertension. Thakkar V; Nikpour M; Stevens WM; Proudman SM Intern Med J; 2015 Mar; 45(3):248-54. PubMed ID: 25735576 [TBL] [Abstract][Full Text] [Related]
36. Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines. Pellar RE; Pope JE Semin Arthritis Rheum; 2017 Jun; 46(6):767-774. PubMed ID: 28088339 [TBL] [Abstract][Full Text] [Related]
37. Determinants of morbidity and mortality of systemic sclerosis in Canada. Al-Dhaher FF; Pope JE; Ouimet JM Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680 [TBL] [Abstract][Full Text] [Related]
38. Scleroderma--clinical and pathological advances. Denton CP; Black CM Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):271-90. PubMed ID: 15158741 [TBL] [Abstract][Full Text] [Related]
39. Is there evidence for vasculitis in systemic sclerosis? Saketkoo LA; Distler O Curr Rheumatol Rep; 2012 Dec; 14(6):516-25. PubMed ID: 23065452 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Vemulapalli S; Cohen L; Hsu V Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]